Document is current
Any future updates will be listed below
-
Authors
Shields, Adrian M.
Faustini, Sian E.
Hill, Harriet J.
Al-Taei, Saly
Tanner, Chloe
Ashford, Fiona
Workman, Sarita
Moreira, Fernando
Verma, Nisha
Wagg, Hollie
Heritage, Gail
Campton, Naomi
Stamataki, Zania
Klenerman, Paul
Thaventhiran, James E. D.
Goddard, Sarah
Johnston, Sarah
Huissoon, Aarnoud
Bethune, Claire
Elcombe, Suzanne
Lowe, David M.
Patel, Smita Y.
Savic, Sinisa
Burns, Siobhan O.
Richter, Alex G.
,
Ahmed, Zahra
Bancroft, Hollie
Bates, Michelle
Clifford, Hayley
Davis, Georgina
Dasgin, Joanne
Dinally, Mohammad
Dhalla, Fatima
Efstathiou, Elena
Elkhalifa, Shuayb
Gompels, Mark
Hartland, Dan
Hoque, Madeeha
Heritage, Emily
Hughes, Deborah
Ivory, Ann
Jain, Rashmi
Kelly, Sinead
McCarthy, Theresa
McGee, Christopher
Mullan, Daniel
Morsi, Hadeil
O’Grady, Eileen
Page, Shannon
Peters, Nicholas
Plant, Timothy
Shajidevadas, Archana
Slowinsksa, Malgorzata
Suleiman, Zehra
Townsend, Neil
Trinham, Charlotte
Wareham, Stuart
Walder, Sinead
-
Funding
Funding for this research was provided by:
UK Research and Innovation (MR/W002663/1)
- License Information
-
More Information
Article History
Received: 21 December 2021
Accepted: 10 February 2022
First Online: 14 April 2022
Declarations
:
: This study was approved by the London — Dulwich Research Ethics Committee (REC reference: 21/LO/0162) and funded by the UK Research and Innovation (MR/W002663/1). Serological responses from healthy individuals are from participants recruited to the COVID-19 convalescent (COCO) immunity study (REC reference 20/HRA/1817). All participants provided written informed consent prior to participation in this study.
: All participants provided written informed consent prior to participation in the COV-AD study.
: Not applicable.
: The authors declare no competing interests.
